Company news

GSK plc news in 2022

GSK plc's news releases, calls and decks from 2022, newest first.

View company

Appointments to Designate Haleon Board

March 15, 2022

GSK Annual Report 2021 on Form 20-F

March 8, 2022

GSK publishes Annual Report 2021

March 4, 2022

Daprodustat application accepted for review by EMA

March 1, 2022

GSK introduces Haleon to investors

February 28, 2022

GSK RSV maternal vaccine candidate further update

February 28, 2022

Canada Approval For Medicago GSK Covid-19 Vaccine

February 24, 2022

GSK Consumer Healthcare to be called Haleon

February 22, 2022

GSK gives update on RSV maternal vaccine candidate

February 18, 2022

Benlysta approved in China for Lupus Nephritis

February 10, 2022

Publication of full year 2021 results: Replacement

February 7, 2022

Publication of full year 2021 results

February 7, 2022

GSK announces settlement between ViiV and Gilead

February 2, 2022

FDA approves ViiV Healthcare's sNDA for Cabenuva

February 1, 2022

Tony Wood appointed CSO Designate, GSK

January 19, 2022

Update - GSK Consumer Healthcare

January 17, 2022

US Govt buys additional 600,000 sotrovimab doses

January 11, 2022

← Newer news releases

Calls in 2022

Decks in 2022